XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way
Related Experiment Video
Updated: Dec 8, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Ruili Huang1, Lijuan Zhu1, Yali Zhang1
1Department of Gynaecology and Obstetrics, The First People's Hospital of Shangqiu, Henan, No. 292 Kaixuan South Road, 476100 Shangqiu, Henan People's Republic of China.
Background/Aims:
The expression levels of long non-coding RNA XIST are significantly associated with paclitaxel (Pac) sensitivity in ovarian cancer, but the mechanism of action remains unclear. Therefore, this experimental design was based on lncRNA XIST analysis to regulate the effect of XIST on the tumor stem cell and paclitaxel sensitivity in ovarian cancer.
Methods:
Sphere assay and fluorescence activated cell sorting (FACS) were used to determine the expression levels of XIST and sensitivity to paclitaxel treatment. The effect of the proliferation was detected by MTT assay. Target gene prediction and screening, luciferase reporter assays were used to validate downstream target genes for lncRNA XIS and KMT2C. The expression of KMT2C was detected by RT-qPCR and Western blotting. RT-qPCR was used to detect the expression of cancer stem cell-associated genes SOX2, OCT4 and Nanog. The tumor changes in mice were detected by in vivo experiments in nude mice.
Results:
There was an inverse correlation between the expression of XIST and cancer stem cell (CD44 + /CD24-) population. XIST promoted methylation of histone H3 methylation at lysine 4 by enhancing the stability of lysine (K)-specific methyltransferase 2C (KMT2C) mRNA. XIST acted on the stability of KMT2C mRNA by directly targeting miR-93-5p. Overexpression of miR-93-5p can reverse the XIST overexpression-induced KMT2C decrease and sphere number increase. Overexpression of KMT2C inhibited XIST silencing-induced proliferation of cancer stem cells, and KMT2C was able to mediate paclitaxel resistance induced by XIST in ovarian cancer. The study found that XIST can affect the expression of KMT2C in the ovarian cancer via targeting miR-93-5p.
Conclusion:
XIST promoted the sensitivity of ovarian cancer stem cells to paclitaxel in a KMT2C-dependent manner.
Insights
Long non-coding RNA XIST enhances paclitaxel sensitivity in ovarian cancer by regulating KMT2C stability, impacting tumor stem cells. This study clarifies XIST
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Long non-coding RNA XIST expression is linked to paclitaxel sensitivity in ovarian cancer.
- The precise mechanism by which XIST influences ovarian cancer stem cells and drug response remains unclear.
Purpose of the Study:
- To investigate the role of XIST in regulating ovarian cancer stem cells.
- To elucidate the mechanism of XIST action on paclitaxel sensitivity in ovarian cancer.
Main Methods:
- Sphere assays, FACS, and MTT assays were used to assess cancer stem cell populations and proliferation.
- Luciferase reporter assays and RT-qPCR validated the interaction between XIST, miR-93-5p, and KMT2C.
- In vivo experiments in nude mice evaluated tumor growth and response to paclitaxel.
Main Results:
- XIST expression inversely correlated with the cancer stem cell population (CD44+/CD24-).
- XIST enhances KMT2C mRNA stability, promoting histone methylation and affecting cancer stem cell proliferation.
- XIST targets miR-93-5p to regulate KMT2C, thereby influencing paclitaxel resistance in ovarian cancer.
Conclusions:
- XIST promotes paclitaxel sensitivity in ovarian cancer stem cells through a KMT2C-dependent pathway.
- Understanding the XIST/miR-93-5p/KMT2C axis offers potential therapeutic targets for improving ovarian cancer treatment.
Related Concept Videos
Drugs that Stabilize Microtubules
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

